Table 5.
The results of subgroup analysis for ORs between sarcopenia and depression
| Outcomes | Numbers of studies | Meta‐analysis results | I 2 (%) | P |
|---|---|---|---|---|
| Diagnostic criteria for sarcopenia | ||||
| AWGS | 8 | 1.85 (1.30–2.63) | 77.0 | <0.001 |
| EWGSOP | 6 | 1.60 (1.07–2.40) | 75.9 | <0.001 |
| FNIH | 1 | 2.23 (1.11–4.48) | / | / |
| Measurement method for LMM | ||||
| BIA | 12 | 1.58 (1.32–1.89) | 76.4 | <0.001 |
| DEXA | 1 | 5.45 (1.06–27.92) | / | / |
| Calf circumference | 2 | 1.37 (0.45–4.16) | 80.9 | 0.022 |
| Measurement method for depression | ||||
| GDS‐15 | 5 | 1.54 (1.04–2.29) | 60.5 | 0.019 |
| GDS | 4 | 2.02 (1.52–2.69) | 14.3 | 0.323 |
| CISR‐B | 1 | 2.23 (1.11–4.48) | / | / |
| CES‐D | 1 | 5.45 (1.06–27.92) | / | / |
| SDS | 1 | 1.05 (0.99–1.11) | / | / |
| HADS | 1 | 1.10 (1.02–1.19) | / | / |
| BDI‐II | 2 | 4.46 (2.03–9.81) | 0 | 0.353 |
| BMI | ||||
| Overweight | 4 | 1.81 (1.01–3.25) | 72.1 | 0.013 |
| Normal | 8 | 1.95 (1.34–2.82) | 79.6 | <0.001 |
| Unknown | 3 | 1.45 (0.78–2.71) | 75.6 | 0.006 |
| Ethnicity | ||||
| Asia | 12 | 1.97 (1.45–2.67) | 77.7 | <0.001 |
| America | 2 | 1.31 (0.49–3.49) | 80.8 | 0.022 |
| Europe | 1 | 1.10 (1.02–1.19) | / | / |
| Site | ||||
| Community | 12 | 1.47 (1.24–1.75) | 75.4 | <0.001 |
| Clinic | 1 | 1.50 (0.90–2.48) | / | / |
| Hospital | 2 | 4.46 (2.03–9.81) | 0 | 0.353 |
Abbreviations: BIA, bioelectrical impedance analysis; CES‐D, Center for Epidemiologic Studies Depression Scale; DEXA, dual‐energy X‐ray absorptiometry; GDS, Geriatric Depression Scale; GDS‐15, 15‐item Geriatric Depression Scale; SDS, Self‐rating Depression Scale; CISR‐B, Brazilian version of the Clinical Interview Scheduled Revised; HADS, Hospital Anxiety and Depression Scale.